Heartseed (219A) · RiskMitigated
Risk of external supply of raw materials and supplies
First written in FY2024. 1 of 2 entries say "Mitigated", first in FY2025. Latest entry: FY2025.
2entries
2years
0from disclosures
How it moved
Same theme, other companies
Business Stagnation Risk from Manufacturing Site Shutdowns and Dependence on Supply to Specific Business PartnersA theme 8 companies write about · 7 as a headwind · 1 as a tailwind
The whole theme swung hardest in 2024: 1 of 6 companies on the "Worse" side.
0 other companies' latest entry also says "Mitigated".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
- FY2025MitigatedAnnual report
「In this regard, we are working to secure stable supply by entering into supply agreements with cooperating companies.」
The Company has stated that it will address supply risks involving needles, catheters and reagents by entering into supply agreements with cooperating companies. - FY2024First statedAnnual report
「In particular, the raw materials and reagents used in the manufacturing process, and needles and catheters used for administration, have limited substitutes. Even if alternatives could be adopted, doing so could significantly delay the current development schedule.」
The Company identifies the risks of external supply interruptions or quality deterioration involving reagents, raw materials, needles and catheters, and the difficulty of obtaining alternatives.